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In the present study, effect of ethanolic extract of bark of Tectona grandis Linn. (TG) was evaluated 
using alloxan induced diabetes and associated renal complication. The diabetes was induced by 
administration of alloxan to the rats at the dose of 140 mg/kg, i.p. TG was administered to diabetic 
animals for six weeks and various biochemical parameters in blood and urine (plasma glucose, serum 
albumin, total protein, and creatinine, urine total protein, urine albumin), tissue parameters 
(cholesterol and triglyceride in kidney homogenate) and % change in body weight were evaluated 
along with histopathological study. In present study diabetic animals treated with TG showed 
significant reduction in the elevated level of plasma glucose (p<0.01) when compared with diabetic 
control. While considering renal parameters, diabetic animals treated with TG showed significant 
decrease in serum creatinine (p<0.05), urine albumin and urine total protein levels (p<0.01) and 
significant increase in serum albumin, total protein and % change in body weight (p<0.01) when 
compared with diabetic control. Diabetic control showed significant increase in total cholesterol and 
triglyceride accumulation in kidney, while diabetic animals treated with TG showed significant 
decrease in levels of total cholesterol (p<0.01) and triglyceride (p<0.05) in the kidney when compared 
with diabetic control. Diabetic control showed significant mark of glomerulosclerosis and 
hyalinization which occurs because of severe diabetic condition (diabetic nephropathy). Diabetic 
groups treated with TG showed absence of the sclerotic lesions produced by diabetic condition. Hence, 
the results obtained in the present study indicate that Tectona grandis has the potential to treat diabetes 
mellitus and prevent the associated renal damage. 
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INTRODUCTION 
Diabetes has become a major health issue in South-East Asia. It has been estimated by 
the international diabetes federation (IDF) that 23 million people have diabetes, which 
accounts for a sixth of the world’s diabetic population. India has the largest diabetic 
population and one of the highest diabetes prevalence rates in the world. The prevalence rates 
for type II diabetes in India are still increasing sharply with the number of sufferers predicted 
to rise from 19.4 million in 1995 to 80.9 million in 2030. With the current high mortality and 
morbidity rates associated with diabetes, this represents a real threat to the economic 
productivity of countries such as India
1
. 
Diabetic nephropathy (DNP) is a major cause of illness and premature death in 
diabetic patients, largely through accompanying cardiovascular diseases and end-stage renal 
failure
2
. Diabetes induced by alloxan in rats results in development of nephropathy similar to 
early stage clinical diabetic nephropathy
3
. 
Diabetes mellitus is not a single disease entity, but rather a group of metabolic 
disorders sharing a common underlying feature of hyperglycemia. Hyperglycemia in diabetes, 
results from defects in insulin secretion, insulin action or most commonly both4. 
Traditionally Tectona grandis is used in treatment of diabetes, lipid disorders, 
inflammation, ulcer, and bronchitis
5







, and anticancer activity
9
. The present study was aimed to 
evaluate the effect of Tectona grandis Linn. in the treatment of diabetes and associated renal 
damage in alloxan induced diabetic rats.  
MATERIALS AND METHODS 
EXPERIMENTAL 
Animals 
Albino rats of Wistar strain weighing 160-200 g and Albino mice weighing 20-30 g 
were obtained from National Toxicology Centre (NTC), Pune. Animals of either sex were 
housed under standard laboratory conditions of 22 ± 3 0C temperature and relative humidity 
30% and 12 h light and dark cycle, free access to standard pellet diet and water ad libitum. 
The Institutional Animal Ethics Committee approved the experimental protocol. IAEC 
registration no (198/99/CPCSEA). 
Collection and Authentication of Plant Material 
The bark of Tectona grandis Linn. (Verbenaceae) was collected in the month of June 
2007 from Nanded, Maharashtra, India. The plant was authenticated by Dr. A. M. Mujumdar 
(Head, Plant Sciences Division) Agharkar Research Institute, Pune as Tectona grandis Linn. 
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(Verbenaceae) with a voucher specimen no Auth08-012. 
Preparation of Extract 
 The bark was washed with distilled water and shed dried and latter powdered. This 
powder was then defatted with petroleum ether and then macerated with ethanol for 72 h with 
occasional shaking. It was then filtered and the solvent was evaporated under vacuum. The 




The acute toxicity study for ethanolic extract of bark of Tectona grandis Linn. (TG) 
was performed using albino mice. The animals were fasted overnight prior to the experiment 
and maintained under standard conditions. TG was found safe up to dose of 2,000 mg/kg, p.o. 
Alloxan Induced Diabetes in Rats
11-14
. 
Induction of Diabetes 
Diabetes was induced by a single intraperitonial injection of alloxan monohydrate in 
citrate buffer (pH 4.5) at a dose of 140 mg/kg, body weight of the rat. The diabetic state was 
confirmed 48 h after alloxan injection by hyperglycemia. Surviving rats with fasting blood 
glucose level higher than 250 mg/dl were included in the study. 
Treatment Schedule 
Total of 25 diabetic surviving and 5 nondiabetic rats were divided in to 6 groups (n=5) 
as follows- 
Group-I nondiabetic animals: received only 1% gum acacia (1 ml/kg/day, p.o.) for six 
weeks, and served as control. Group-II to VI were rendered diabetic by single intraperitonial 
dose of alloxan monohyderate 140 mg/kg, in citrate buffer (pH 4.5). Group II received 1 % 
gum acacia (1 ml/kg/day, p.o.) for six weeks and served as diabetic control. Group-III 
received glimepride (0.09 mg/kg/day, p.o.) for six weeks. Group-IV-VI received three 
different doses of TG (50, 100 and 200 mg/kg/day, p.o.) for six weeks respectively. 
Biochemical Parameters from Blood and Urine 
On 1st day and at the end of each week of treatment, blood was withdrawn from all the 
animals under light ether anaesthesia by puncturing retro-orbital plexus. Estimation of plasma 
glucose (GOD/POD Method), serum albumin, total protein (Biuret and Dye binding method) 
and Creatinine (Alkaline picrate method) using standard diagnostic kits from BIOLAB 
Diagnostics (P) Ltd., India. 
At the end of the study urine was collected and centrifuged. Levels of total protein and 
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albumin were estimated (Biuret and Dye binding method) using standard diagnostic kits from 
BIOLAB Diagnostics (P) Ltd., India. 
Study of Morphometric Parameters 
 Body weight was recorded throughout the study period.  
Study of Biochemical Parameters from Kidney 
At the end of experimental period, the animals were sacrificed with overdose of 
urethane. The kidney was removed. 10% homogenate of kidney was prepared in 50 mM 
phosphate buffer (pH 7.4) and centrifuged. The supernatant was used for the estimation of 
total cholesterol (COD/POD Method) and triglyceride (GPO/POD Method) using standard 
diagnostic kits from BIOLAB Diagnostics (P) Ltd., India. 
Histopathological Studies 
The kidney was removed from single animal of each group, washed with distilled 
water and kept in 10% formalin solution; and stained with H&E and then examined for the 
microscopic morphology. 
Statistical Analysis  
Results were expressed as Mean ± SEM and analysed by ANOVA followed by 
Dunnett test p<0.05 considered as statistical significant. 
RESULTS 
Effect of Tectona grandis on Biochemical Parameters 
Diabetic control showed significant increase in plasma glucose level, serum creatinine, 
urine albumin and total protein levels (p<0.01) (Figures 1-3) and significant decrease in serum 
albumin, total protein levels and % change in body weight (p<0.01) (Figures 4-6) when 
compared with control animals. In the present study diabetic animals treated with TG showed 
significant reduction in the elevated level of plasma glucose (p<0.01) when compared with 
diabetic control (Figure 1). While considering renal parameters, diabetic animals treated with 
TG showed significant decrease in serum creatinine (p<0.05) (Figure 2) and urine albumin 
and total protein levels (p<0.01) (Figure 3) and significant increase in serum albumin, total 
protein and % change in body weight (p<0.01) when compared with diabetic control (Figures 
4-6). Diabetic control showed significant increase in total cholesterol and triglyceride 
accumulation in kidney, while diabetic animals treated with TG showed significant decrease 
in levels of total cholesterol (p<0.01) and triglyceride (p<0.05) in the kidney homogenate 
when compared with diabetic control (Figure 7). 
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Figure 1. Effect of Tectona grandis Linn. on plasma glucose level in alloxan induced diabetic rats 
 
Values are expressed as Mean ± SEM. (n=5), ANOVA followed by Dunnett test. ##p<0.01 
when compared with Control; *p<0.05, **p<0.01 when compared with Diabetic control. 
 
 














































Values are expressed as Mean ± SEM. (n=5), ANOVA followed by Dunnett test. ##p<0.01 
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Day-1 Day 15 Day 29 Day 43
Values are expressed as Mean ± SEM. (n=5), ANOVA followed by Dunnett test. ##p<0.01 
when compared with Control; *p<0.05, **p<0.01 when compared with Diabetic control. 
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Values are expressed as Mean ± SEM. (n=5), ANOVA followed by Dunnett test. ##p<0.01 
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Values are expressed as Mean ± SEM. (n=5), ANOVA followed by Dunnett test. ##p<0.01 
when compared with Control; *p<0.05, **p<0.01 when compared with Diabetic control. 
 
Figure 6. Effect of Tectona grandis Linn. on urine total protein and urine albumin level in alloxan-
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Values are expressed as Mean ± SEM. (n=5), ANOVA followed by Dunnett test. ##p<0.01 
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Figure 7. Effect of Tectona grandis Linn. on total cholesterol and triglyceride levels in kidney 


























































Total Cholesterol (mg/g) Triglyceride (mg/g)
 
Values are expressed as Mean ± SEM. (n=5), ANOVA followed by Dunnett test. ##p<0.01 
when compared with Control; *p<0.05, **p<0.01 when compared with Diabetic control. 
Effect of Tectona grandis on histopathology of kidney 
 In present study, histopathology of control group showed normal structure of 
glomerulus, while diabetic control group showed significant mark of glomerulosclerosis and 
hyalinization which occurs because of severe diabetic condition (diabetic nephropathy). 
Diabetic group treated with TG 200 mg/kg, p.o. showed absence of the sclerotic lesions 
produced by diabetic condition. While TG 100 mg/kg, p.o. treated and glimepride treated 
diabetic groups showed partial prevention of the hyalinization but failed to recover the 
glomerulosclerosis to the normal condition. Diabetic group treated with TG 50 mg/kg, p.o. 
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Figure 8.  Effect of Tectona grandis Linn. on histopathological studies of kidney in alloxan-induced 
diabetic rats. 
                                    






                                                                                      
                                                             
 
 











Photomicrograph of Control 
group kidney showing normal 
structure of glomerulus showing 
normal structure of glomerulus 
(H & E 100X) 
Photomicrograph of Diabetic 
control group kidney showing 
significant mark of 
glomerulosclerosis (nephritis) 
and Hyalinization (H & E 100X) 
Photomicrograph of Glim group 
kidney showing mild 
glomerulosclerosis (nephritis) 
and Hyalinization (H & E 100X) 
Photomicrograph of TG-100 
group kidney showing mild 
glomerulosclerosis (nephritis) but 
no sign of Hylinization (H & E 
100X) 
Photomicrograph of TG-50 
group kidney showing 
significant glomerulosclerosis 
(nephritis) and mild Hylinization 
(H & E 100X) 
Photomicrograph of TG-200 
group kidney showing Very mild 
glomerulosclerosis (nephritis) but 
no sign of Hylinization (H & E 
100X) 
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DISCUSSION 
Diabetes mellitus ranks highly among the top ten disorders which cause mortality 
throughout the world. Diabetes mellitus being chronic disorder, treatment without side effect 
for long term control is important. Present antidiabetic agent possess side effect as risk of 
hypoglycemia, anemia, choestatic jaundice
15
. There has been growing public interest in herbal 
medication for treatment of diabetes.  
In the present study the periodic estimation of plasma glucose revealed that TG 
produced significant antihyperglycemic activity which began from 22
nd 
day of treatment and 
it progressed throughout the study. The antidiabetic effect of the TG could possibly be due to 
presence of glycosides, terpenoids, tannins and saponins. Substances like glycosides, 




Various reports suggest that there is reduction in the body weight in diabetic rats
3
. 
Loss of body weight could be due to, dehydration and catabolism of fats and protein seen 
during diabetes mellitus17. It is reported that the recovery in body weight is far less in the 
poorly controlled diabetic rats as compared to well-controlled diabetic rats. In the present 
study diabetic control group rats showed significant loss of body weight. All animals treated 
with TG showed significant prevention of the loss in body weight throughout the study. This 
prevention of loss in body weight by TG may be due to increasing glucose uptake in 
peripheral tissues or inhibiting catabolism of fat and protein or by glycemic control. 
Diabetes produces qualitative and quantitative changes in the composition of the 
basement membrane and this altered material undergoes accelerated glycosylation and further 
rearrangement to form advanced glycation end-products (AGEs), which stimulate protein 
synthesis, further decrease degradability of the basement membrane, increase its permeability 
and cause endothelial dysfunction. Hyperglycemia increases the expression of transforming 
growth factor beta (TGFβ) in the glomeruli and of matrix protein specifically stimulated by 
cytokine. TGFβ may contribute to both the cellular hypertrophy and enhanced collagen 
synthesis is observed in diabetic nephropathy
18
. 
During diabetes, there is increased protein catabolism with inflow of amino acids to 
liver, which feed gluconeogenesis and accelerate ureagenesis, resulting in hypoproteinemia 
and hypoalbuminemia
19
. Diabetic hyperglycemia induces elevation of the levels of serum 




In the present study, diabetic animals treated TG showed reduction in proteinurea and 
albuminurea and also showed improvement in the serum total protein and albumin level. 
Treatment with TG also prevented the rise in serum creatinine levels. These results indicate 
that TG attenuates the progression of renal damage in alloxan induced diabetic rats.  
The use of typical antioxidants alone or in combination may retard or even prevent the 
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normal progression of diabetic complications
21
. 
In case of uncontrolled diabetes there is accumulation of lipids in kidney. Excessive 
production and accumulation of lipids can have devastating effect on renal structure and 
function
22
. Changes in the fractions of the lipid in renal cortex and medulla readily show its 
abnormality in diabetes
23
. In the present study it was found that concentrations of total lipids 
were significantly increased in cortical and medullary region of the kidney; concentration of 
total cholesterol was significantly increased in cortical region. TG treated diabetic rats 
showed significant reduction in the total cholesterol and triglyceride level in the kidney 
homogenate. The glycemic control exerted by TG may have affected the dislipidemia and the 
subsequent accumulation of the lipids in the kidney. 
The histopathological study of diabetic control group showed significant mark of 
glomerulosclerosis and hyalinization which was probably due to severe diabetic condition 
(diabetic nephropathy); and the diabetic groups treated with TG showed absence of the 
sclerotic lesions produced by diabetic condition indicating the protective effect of TG on the 
kidneys of the diabetic animals.  
Hence, the results obtained in the present study indicate that Tectona grandis has the 
potential to treat diabetes mellitus and prevent diabetes mellitus associated renal damage. 
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